Black Rock Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,025,007 shares of ALNY stock, worth $2.19 Billion. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,025,007
Previous 8,521,115
5.91%
Holding current value
$2.19 Billion
Previous $1.63 Billion
17.3%
% of portfolio
0.03%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
584Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.11 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.91 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.75 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.61 Billion0.78% of portfolio
-
Dodge & Cox San Francisco, CA3.81MShares$926 Million0.35% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...